Le Lézard
Classified in: Health

GE Healthcare and Sepsis Alliance Collaborate to Improve Treatment of Sepsis - Leading Cause of Death in U.S. Hospitals


SAN DIEGO, Nov. 22, 2019 /PRNewswire-PRWeb/ -- Sepsis Alliance, the nation's first and leading sepsis organization, and GE Healthcare, a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, today announced their collaboration to improve sepsis treatment and to help save lives. As part of this relationship, GE Healthcare is sponsoring the webinar series, Can We Help 'Solve' Sepsis, Together, and is supporting the Sepsis Coordinator Network.

Sepsis is the body's life-threatening response to infections that takes an estimated 270,000 lives each year in the United States. It claims more lives than opioid overdoses, breast cancer, and prostate cancer combined. Can We Help 'Solve' Sepsis, Together, a four-part installment of the Sepsis Alliance innovation webinar series developed and presented by GE Healthcare experts, aims to empower healthcare providers with the latest innovations and research in sepsis care to help improve outcomes for sepsis patients and to help save lives.

"Educating healthcare providers about the latest innovations in sepsis treatment is key to not only reducing sepsis mortality but to improving overall patient outcomes," said Thomas Heymann, President and Executive Director, Sepsis Alliance. "Without committed partners like GE Healthcare, Sepsis Alliance would not be able to offer healthcare providers with our vast library of educational webinars and resources, or with platforms like the Sepsis Coordinator Network."

In a further commitment to improving sepsis treatment, GE Healthcare became a sponsor of the Sepsis Coordinator Network (SCN), a peer-to-peer online community created by Sepsis Alliance. The SCN offers sepsis best practice resources and guidance to sepsis coordinators and all health professionals across the country. It has more than 2,000 members from 1,700 hospitals and facilities, and its members cover more than 572,000 hospital beds.

"Our ultimate goal in our collaboration with Roche Diagnostics is to empower health care providers with high-quality insights that can guide action for patients before sepsis-related decline requires heroic and expensive measures," said Paul Mullen, general manager of GE Healthcare Acute Care. "Education about patient deterioration is a critical aspect of our work, making our involvement with Sepsis Alliance particularly meaningful and important."

To download past webinars of the Can We Help 'Solve' Sepsis, Together series and to learn about upcoming webinars in this series, visit http://www.sepsiswebinar.org. To learn more about and to join the SCN, visit http://www.sepsiscoordinatornetwork.org.

About Sepsis Alliance:
Sepsis Alliance is the leading sepsis organization in the U.S., working in all 50 states to save lives and reduce suffering by raising awareness of sepsis as a medical emergency. In 2011, Sepsis Alliance designated September as Sepsis Awareness Month to bring healthcare professionals and community members together in the fight against sepsis. In 2018, Sepsis Alliance created the award-winning national campaign, It's About T.I.M.E.tm, to educate the public about the signs and symptoms of sepsis and to highlight the urgent need to seek treatment when symptoms are recognized. Sepsis Alliance gives a voice to the millions of people who have been touched by sepsis ? to the survivors, and the friends and family members of those who have survived or who have died. Since 2003, sepsis awareness in the U.S. has risen from 19% to 65%. Sepsis Alliance is a GuideStar Platinum Rated charity. For more information, please visit http://www.sepsis.org. Connect with us on Facebook and Twitter at @SepsisAlliance.

About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE. As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and Insights for latest news, or visit our website https://corporate.gehealthcare.com/ for more information.

 

SOURCE Sepsis Alliance


These press releases may also interest you

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...



News published on and distributed by: